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Background: We assessed the comparative prognostic role of left ventricular hypertrophy (LVH) and chronic kidney disease (CKD) for major CV 
events in a prospective observational study in Greek essential hypertensives.
Methods: We followed-up 1652 hypertensives (mean age 54.3 years, 696 males, office BP=147/93 mmHg) free of CV disease for a mean period 
of 6 years. CKD (according to MDRD estimated GFR) and echocardiographically detected LVH were evaluated at baseline along with five major 
traditional risk factors [age>65, gender, current smoking, diabetes mellitus (DM) and dyslipidemia (LDL>160mg/dl)]. End-points of interest were 
the incidence of coronary artery disease (CAD), stroke, all cause mortality and their composite. The cumulative incidence of studied end-points was 
calculated using the group without LVH and CKD as a reference for each other.
Results: The incidence of LVH and CKD was 35.6% and 13%, respectively. At the end of follow up, CAD was the most prevalent (5.2%), followed 
by stroke (5%) and total mortality (3.1%). The presence of both LVH and CKD is associated with a 2.5 fold increased risk for CAD (p=0.034), 4 
fold for stroke (p=0.002) and 3.2 fold for the composite (p<0.001), while the presence only of LVH was associated with a 2.5 fold higher risk for 
stroke (p=0.009) and 1.7 fold higher risk for the composite (p=0.018). By multivariate Cox regression analysis, age>65 (HR 3.73, p<0.001), male 
gender (HR 1.98, p=0.001), along with LVH (HR 1.53, p=0.036) and CKD (HR 1.66, p=0.039) turned out to be independent prognosticators of 
the composite end-point. Moreover, age>65 (HR 2.51, p=0.002), male gender (HR 2.14, p=0.012) and DM (HR 2.96, p=0.002) were independent 
predictors of CAD, as well as, age>65 (HR 4.59, p<0.001) and the presence of LVH (HR 2.01, p=0.043) were prognosticators of stroke.
Conclusions: In hypertensive subjects free of CV disease, CKD and LVH are both independent prognosticators of the composite end-point of all-
cause death and CV morbidity, whereas LVH but not CKD is a major predictor for stroke. Moreover, their combination is accompanied by increased 
incidence of CAD, stroke and composite, further supporting the adverse prognosis associated with cardiorenal dysfunction.
